Melatonin and atopy: Role in atopic dermatitis and asthma

International Journal of Molecular Sciences

Volumn 15, Issue 8, 2014, Pages 13482-13493

  Marseglia, Lucia ^a   D'Angelo, Gabriella ^a   Barberi, Ignazio ^a   Manti, Sara ^a   Salpietro, Carmelo ^a   Arrigo, Teresa ^a   Reiter, Russel J ^b   Gitto, Eloisa ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Allergy; Atopic eczema; Bronchial asthma; Melatonin

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; MELATONIN;

ASTHMA; ATOPIC DERMATITIS; BLOOD; HUMAN; IMMUNOMODULATION; METABOLISM; PATHOLOGY;

ASTHMA; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; IMMUNOMODULATION; INTERLEUKIN-4; MELATONIN;

EID: 84905640993     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150813482     Document Type: Review

References (90)

1. Johansson, S.G.; Hourihane, J.O.; Bousquet, J.; Bruijnzeel-Koomen, C.; Dreborg, S.; Haahtela, T.; Kowalski, M.L.; Mygind, N.; Ring, J.; van Cauwenberge, P.;et al. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56, 813-824.
2. Romagnani, S. Induction of TH1 and TH2 responses: A key role for the natural immune response? Immunol. Today 1992, 13, 379-381.
3. Brown, V.G.; Ennis, M. T cell cytokine production in childhood asthma. Curr. Respir. Med. Rev. 2005, 1, 1-6.
4. Cohn, L.; Elias, J.A.; Chupp, G.L. Asthma: Mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004, 22, 789-815.
5. Schmidt-Weber, C.B.; Akdis, M.; Akdis, C.A. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 2007, 120, 247-254.
6. Moore, K.W.; de Waal Malefyt, R.; Coffman, R.L.; O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19, 683-765.
7. Wakashin, H.; Hirose, K.; Maezawa, Y.; Kagami, S.; Suto, A.; Watanabe, N.; Saito, Y.; Hatano, M.; Tokuhisa, T.; Iwakura, Y.;et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008, 178, 1023-1032.
8. Reiter, R.J. Pineal melatonin: Cell biology of its synthesis and ofits physiological interactions. Endocr. Rev. 1991, 12, 151-180.
9. Slominski, A.; Wortsman, J.; Tobin, D.J. The cutaneous serotoninergic/melatoninergic system: Securing a place under the sun. FASEB J. 2005, 19, 176-194.
10. Slominski, A.; Fischer, T.W.; Zmijewski, M.A.; Wortsman, J.; Semak, I.; Zbytek, B.; Slominski, R.M.; Tobin, D.J. On the role ofmelatonin in skin physiology and pathology. Endocrine 2005, 27, 137-148.
11. Hardeland, R. Antioxidative protection by melatonin: Multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005, 27, 119-130.
12. Galano, A.; Tan, D.X.; Reiter, R.J. Melatonin asa natural ally against oxidative stress: A physicochemical examination. J. Pineal Res. 2011, 51, 1-16.
13. Galano, A.; Tan, D.X.; Reiter, R.J. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J. Pineal Res. 2013, 54, 245-257.
14. Mauriz, J.L.; Collado, P.S.; Veneroso, C.; Reiter, R.J.; González-Gallego, J. A review of the molecular aspects of melatonin's anti-inflammatory actions: Recent insights and new perspectives. J. Pineal Res. 2013, 54, 1-14.
15. Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolín, I.; Herrera, F.; Martín, V.; Reiter, R.J. Regulation of antioxidant enzymes:A significant role for melatonin.J. Pineal Res. 2004, 36, 1-9.
16. Fischer, T.W.; Kleszczyński, K.; Hardkop, L.H.; Kruse, N.; Zillikens, D. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) inex vivo human skin. J. Pineal Res. 2013, 54, 303-312.
17. García, J.J.; López-Pingarrón, L.; Almeida-Souza, P.; Tres, A.; Escudero, P.; García-Gil, F.A.; Tan, D.X.; Reiter, R.J.; Ramírez, J.M.; Bernal-Pérez, M. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: A review. J. Pineal Res. 2014, 56, 225-237.
18. Arendt, J. Melatonin, circadian rhythms, and sleep. N. Engl. J. Med. 2000, 343, 1114-1116.
19. Stone, B.M.; Turner, C.; Mills, S.L.; Nicholson, A.N. Hypnotic activity of melatonin. Sleep 2000, 23, 663-669.
20. Brzezinski, A. Melatonin in humans. N. Engl. J. Med. 1997, 336, 186-195.
21. Reiter, R.J.; Tan, D.X.; Fuentes-Broto, L. Melatonin: A multitasking molecule. Prog. Brain Res. 2010, 181, 127-151.
22. Mirick, D.K.; Davis, S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol. Biomark. Prev. 2008, 17, 3306-3313.
23. Mediavilla, M.D.; Sanchez-Barcelo, E.J.; Tan, D.X.; Manchester, L.; Reiter, R.J. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr. Med. Chem. 2010, 17, 4462-4481.
24. Hardeland, R.; Madrid, J.A.; Tan, D.X.; Reiter, R.J. Melatonin, the circadian multioscillator system and health: The need for detailed analyses of peripheral melatonin signaling. J. Pineal Res. 2012, 52, 139-166.
25. Reiter, R.J.; Tan, D.X.; Burkhardt, S. Reactive oxygen and nitrogen species and cellular and organismal decline: Amelioration with melatonin. Mech. Ageing Dev. 2002, 123, 1007-1119.
26. Gitto, E.; Pellegrino, S.; Gitto, P.; Barberi, I.; Reiter, R.J. Oxidative stress of the newborn in the pre-and post-natal period and the clinical utility of melatonin. J. Pineal Res. 2009, 46, 128-139.
27. Schmid-Grendelmeier, P.; Simon, D.; Simon, H.U.; Adkis, C.A.; Wüthrich, B. Epidemiology, clinical features and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001, 56, 841-849.
28. Leung, D.Y.; Bonguniewicz, M.; Howell, M.D. New insights into atopic dermatitis. J. Clin. Investig. 2004, 113, 651-657.
29. Braback, L.; Hjern, A.; Rasmussen, F. Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non-farming environments. A nationwide study over three decades. Clin. Exp. Allergy 2004, 34, 38-43.
30. Novak, N.; Bieber, T. Allergic and non allergic forms of atopic diseases. J. Allergy Clin. Immunol. 2003, 112, 252-262.
31. Leonardi, S.; Miraglia del Giudice, M.; La Rosa, M. Atopic disease, immune system, and the environment. Allergy Asthma Proc. 2007, 28, 410-417.
32. Miraglia del Giudice, M.; Decimo, F.; Leopardi, S. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc. 2006, 27, 451-455.
33. Leonardi, S.; Rotolo, N.; Vitaliti, G. IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome. Allergy Asthma Proc. 2007, 28, 529-534.
34. Grewe, M.; Bruijnzeel-Koomen, C.A.; Schöpf, E.; Thepen, T.; Langeveld-Wildschut, A.G.; Ruzicka, T.; Krutmann, J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 1998, 19, 359-361.
35. Kilanczyk, E.; Bryszewska, M. The effect of melatonin on antioxidant enzymes in human diabetic skin fibroblasts. Cell. Mol. Biol. Lett. 2003, 8, 333-336.
36. Fischer, T.W.; Zbytek, B.; Sayre, R.M.; Apostolov, E.O.; Basnakian, A.G.; Sweatman, T.W.; Wortsman, J.; Elsner, P.; Slominski, A. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J. Pineal Res. 2006, 40, 18-26.
37. Arnetz, B.B.; Berg, M. Melatonin and adrenocorticotropic hormone levelsin video display unit workers during work and leisure. J. Occup. Environ. Med. 1996, 38, 1108-1110.
38. Kimata, H. Reduction of allergen-specific IgE production by laughter. Eur. J. Clin. Investig. 2004, 34, 76-77.
39. Kimata, H. Elevation of salivary melatonin levels by viewing a humorous film in patients with atopic eczema. Horm. Metab. Res. 2007, 39, 310-311.
40. Buscemi, N.; Vandermeer, B.; Pandya, R.; Hooton, N.; Tjosvold, L.; Hartling, L.; Baker, G.; Vohra, S.; Klassen, T. Melatonin for treatment of sleep disorders. Evid. Rep. Technol. Assess. 2004, 108, 1-7.
41. Kim, T.H.; Jung, J.A.; Kim, G.D.; Jang, A.H.; Ahn, H.J.; Park, Y.S.; Park, C.S. Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. J. Pineal Res. 2009, 47, 324-329.
42. Tembhre, M.K.; Sharma, V.K. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Br. J. Dermatol. 2013, 169, 543-548.
43. Petrovsky, N.; Harrison, L.C. The chronobiology of human cytokine production. Int. Rev. Immunol. 1998, 16, 635-649.
44. Dimitrov, S.; Lange, T.; Tieken, S.; Fehm, H.L.; Born, J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav. Immun. 2004, 18, 341-348.
45. Garcia-Maurino, S.; Gonzalez-Haba, M.G.; Calvo, J.R.; Rafii-El-Idrissi, M.; Sanchez-Margalet, V.; Goberna, R.; Guerrero, J.M. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: A possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 1997, 159, 574-581.
46. Garcia-Maurino, S.; Pozo, D.; Carrillo-Vico, A.; Calvo, J.R.; Guerriero, J.M. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 1999, 65, 2143-2150.
47. Maestroni, G.J.; Sulli, A.; Pizzorni, C.; Villaggio, B.; Cutolo, M. Melatonin in rheumatoid arthritis: Synovial macrophages show melatonin receptors. Ann. N. Y. Acad. Sci. 2002, 966, 271-275.
48. Garcia-Maurino, S.; Pozo, D.; Calvo, J.R.; Guerrero, J.M. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J. Pineal Res. 2000, 29, 129-137.
49. Carrillo-Vico, A.; Lardone, P.J.; Fernandez-Santos, J.M.; Martín-Lacave, I.; Calvo, J.R.; Karasek, M.; Guerrero, J.M. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J. Clin. Endocrinol. Metab. 2005, 90, 992-1000.
50. Miller, S.C.; Pandi, P.S.; Esquifino, A.I.; Cardinali, D.P.; Maestroni, G.J. The role of melatonin in immunoenhancement: Potential application in cancer. Int. J. Exp. Pathol. 2006, 87, 81-87.
51. Theoharides, T.C.; Singh, L.K.; Boucher, W.; Pang, X.; Letourneau, R.; Webster, E.; Chrousos, G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998, 139, 403-413.
52. Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 2000, 80, 979-1020.
53. Sivaranjani, N.; Rao, S.V.; Rajeev, G. Role of reactive oxygen species and antioxidants in atopic dermatitis. J. Clin. Diagn. Res. 2013, 7, 2683-2685.
54. Gitto, E.; Marseglia, L.; Manti, S.; D'Angelo, G.; Barberi, I.; Salpietro, C.; Reiter, R.J. Protective role of melatonin in neonatal diseases. Oxidative Med. Cell. Longev. 2013, 2013, 980374:1-980374:6.
55. Schwarz, W.; Birau, N.; Hornstein, O.P.; Heubeck, B.; Schonberger, A.; Meyer, C.; Gottshalk, J. Alterations of melatonin secretion in atopic eczema. Acta Derm. Venerol. 1988, 68, 224-229.
56. Muñoz-Hoyos, A.; Espín-Quirantes, C.; Molina-Carballo, A.; Uberos, J.; Contreras-Chova, F.; Narbona-López, E.; Gutiérrez-Salmerón, M.J. Neuroendocrine and circadian aspects (melatonin and beta-endorphin) of atopic dermatitis in the child. Pediatr. Allergy Immunol. 2007, 18, 679-686.
57. Chamlin, S.L.; Mattson, C.L.; Frieden, I.J.; Williams, M.L.; Mancini, A.J.; Cella, D.; Chren, M.M. The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis. Arch. Pediatr. Adolesc. Med. 2005, 159, 745-750.
58. Buckhalt, J.A.; El-Sheikh, M.; Keller, P.S.; Kelly, R.J. Concurrent and longitudinal relations between children's sleep and cognitive functioning:The moderating role of parent education. Child Dev. 2009, 80, 875-892.
59. Jahnke, G.; Marr, M.; Myers, C.; Wilson, R.; Travlos, G.; Price, C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol. Sci. 1999, 50, 271-279.
60. Sanchez-Barcelo, E.J.; Mediavilla, M.D.; Tan, D.X.; Reiter, R.J. Clinical uses of melatonin: Evaluation of clinical trials. Curr. Med. Chem. 2010, 17, 2070-2095.
61. Chipps, B.E.; Zeiger, R.S.; Borish, L.; Wenzel, S.E.; Yegin, A.; Hayden, M.L.; Miller, D.P.; Bleecker, E.R.; Simons, F.E.; Szefler, S.J.;et al. Key findings and clinicalimplications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) Study. J. Allergy Clin. Immunol. 2012, 130, 332-342.
62. Murray, C.J.L.; Lopez, A.D. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997, 349, 1498-1504.
63. Bowler, R.P.; Crapo, J.D. Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 2002, 110, 349-356.
64. Sackesen, C.; Ercan, H.; Dizdar, E.; Soyer, O.; Gumus, P.; Tosun, B.N.; Büyüktuncer, Z.; Karabulut, E.; Besler, T.; Kalayci, O. A comprehensive evaluation of the enzymatic and non-enzymatic antioxidant systems in childhood asthma. J. Allergy Clin. Immunol. 2008, 12, 78-85.
65. Tekin, D.; Sin, B.A.; Mungan, D.; Misirligil, Z.; Yavuzer, S. The oxidative defense in asthma. J. Asthma 2000, 37, 59-63.
66. Ito, K.; Herbert, C.; Siegle, J.S.; Vuppusetty, C.; Hansbro, N.; Thomas, P.S.; Foster, P.S.; Barnes, P.J.; Kumar, R.K. Steroid-resistant neutrophilic, inflammation in a mouse model of an acute exacerbation of asthma. Am. J. Respir. Cell Mol. Biol. 2008, 39, 543-550.
67. Abboud, R.T.; Vimalanathan, S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Rev. Int. J. Tuberc. Lung Dis. 2008, 12, 361-367.
68. Suzuki, S.; Matsukura, S.; Takeuchi, H.; Kawaguchi, M.; Ieki, K.; Odaka, M.; Watanabe, S.; Homma, T.; Dohi, K.; Aruga, T.;et al. Increase in reactive oxygen metabolite level in acute exacerbations of asthma. Int. Arch. Allergy Immunol. 2008, 1, 67-72.
69. Manrique, H.A.; Gómez, F.P.; Muñoz, P.A.; Peña, A.M.; Barberà, J.A.; Roca, J.; Rodríguez-Roisin, R. Adenosine 5'-monophosphate inasthma: Gas exchange and sputum cellular responses. Eur. Respir. J. 2008, 31, 1205-1212.
70. Gumral, N.; Naziroglu, M.; Ongel, K.; Beydilli, E.D.; Ozguner, F.; Sutcu, R.; Caliskan, S.; Akkaya, A. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods. Cell Biochem. Funct. 2009, 27, 276-283.
71. Martin, R.J. Location of airway inflammation in asthma and the relationship to circadian change in lung function. Chronobiol. Int. 1999, 16, 23-30.
72. Rand, S.E.; Martin, R.J.; Ellison, M.C.; Kraft, M. Immunomodulatory effects of melatonin in asthma. Am. J. Respir. Crit. Care Med. 2002, 166, 1055-1061.
73. Karasu-Minareci, E.; Kaya, Y.; Yildirim, F.B. The achilles heel in melatonin: Asthma. Iran. J. Allergy Asthma Immunol. 2012, 11, 246-251.
74. Martins, E., Jr.; Ligeiro de Oliveira, A.P.; Fialho de Araujo, A.M.; Tavares de Lima, W.; Cipolla-Neto, J.; Costa Rosa, L.F.B.P. Melatonin modulates allergic lung inflammation. J. Pineal Res. 2001, 31, 363-369.
75. Luo, F.; Liu, X.; Li, S.; Liu, C.; Wang, Z. Melatonin promoted chemotaxins expression in lung epithelial cell stimulated with TNF-alpha. Respir. Res. 2004, 10, 5-20.
76. Pang, C.S.; Brown, G.M.; Tang, P.L.; Pang, S.F. G-protein linked melatonin binding sites in the chicken lung. Neurosci. Lett. 1993, 162, 17-20.
77. Weekley, L.B. Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone. Clin. Auton. Res. 1995, 5, 53-56.
78. Sutherland, E.R.; Ellison, M.C.; Kraft, M.; Martin, R.J. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J. Allergy Clin. Immunol. 2003, 112, 513-517.
79. Gumral, N.; Caliskan, S.; Ozguner, F.; Kaleli, S.; Akkaya, A.; Yilmaz, H.; Sens, S. Melatonin levels and enzymatic antioxidant defense systemdecrease in blood of patients with bronchial asthma. Toxicol. Ind. Health 2009, 25, 411-416.
80. Shin, I.S.; Park, J.W.; Shin, N.R.; Jeon, C.M.; Kwon, O.K.; Lee, M.Y.; Kim, H.S.; Kim, J.C.; Oh, S.R.; Ahn, K.S. Melatonin inhibits MUC5AC production via suppression of MAPK signaling in human airway epithelial cells. J. Pineal Res. 2014, 56, 398-407.
81. Lu, T.; Galijasevic, S.; Abdulhamid, I.; Abu-Soud, H.M. Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase. Br. J. Pharmacol. 2008, 154, 1308-1317.
82. Barnes, P.J.; Karin, M. Nuclear factor-B: A pivotal transcription factor in chronic inflammatory disease. N. Engl. J. Med. 1997, 336, 1066-1071.
83. Wang, Y.T.; Chen, S.L.; Xu, S.Y. Effect of melatonin on the expression of nuclear factor-kappa B and airway inflammation in asthmatic rats. Zhonghua Er Ke Za Zhi 2004, 42, 94-97.
84. Lambrecht, B.N.; Hammad, H. Asthma: The importance of dysregulated barrier immunity. Eur. J. Immunol. 2013, 43, 3125-3137.
85. Calvo, J.R.; González-Yanes, C.; Maldonado, M.D. The role of melatonin in the cells of the innate immunity: A review. J. Pineal Res. 2013, 55, 103-120.
86. Koinis-Mitchell, D.; Craig, T.; Esteban, C.A.; Klein, R.B. Sleep and allergic disease: A summary of the literature and futuredirections for research. J. Allergy Clin. Immunol. 2012, 130, 1275-1281.
87. Dean, B.B.; Calimlim, B.C.; Sacco, P.; Aguilar, D.; Maykut, R.; Tinkelman, D. Uncontrolled asthma among children: Impairmentin social functioning and sleep. J. Asthma 2010, 47, 539-544.
88. Luyster, F.S.; Teodorescu, M.; Bleecker, E.; Busse, W.; Calhoun, W.; Castro, M.; Chung, K.F.; Erzurum, S.; Israel, E.; Strollo, P.J.;et al. Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath 2012, 16, 1129-1137.
89. Campos, F.L.; da Silva-Junior, F.P.; de Bruin, V.M.S.; de Bruin, P.F.C. Melatonin improves Sleep in asthma a randomized, double-blind, placebo-controlled study. Am. J. Respir. Crit. Care Med. 2004, 170, 947-951.
90. Sener, G.; Sehirli, O.; Altinbas, H.; Ersoy, Y.; Paskaloglu, K.; Arbak, S.; Ayanoglu, G. Melatonin protects against gentamicin-induced nephrotoxicity in rats. J. Pineal Res. 2002, 32, 231-236.